Bibliography
- Dave H, Ledwani L. A review on anthraquinones isolated from Cassia species and their applications. Indian J Nat Prod Resour 2012;3:291-319
- Shi L, Wang Z, Zhang G, et al. Antitumor activity and preparation of 1,4-dihydroxy-9,10-anthraquinone-2-carboxaldehyde thiosemicarbazone-like compounds. CN102627593A; 2012
- Huang HS. Bis(aminoacylamino) anthraquinone compounds as anticancer agents and manufacturing method thereof. US0145070A1; 2010
- Preobrazhenskaya MN, Shchekotikhin AE, Shtil AA, et al. Antitumor anthraquinone analogues for multidrug resistant tumor cells. J Med Sci 2006;26:1-4
- Hsu SC, Chung JG. Anticancer potential of emodin. Biomedicine 2012;2:108-16
- Kamal A, Bolla NR, Srikanth PS, et al. Naphthalimide derivatives with therapeutic characteristics: a patent review. Expert Opin Ther Patents 2013;23:299-317
- Wang B, Dai C, Draganov A, et al. Preparation of anthraquinone analogs as anti-proliferative agents. WO011753A2; 2014
- Ogrodzinski S, Smith P, Mckeown S, et al. Preparation of anthraquinone compounds targeting tumor hypoxia useful for treatment of cancer. WO023956A1; 2014
- Wu JJQ, Wang L. Preparation of crystalline forms of tyrosine kinase inhibitors and their salts. US0275113A1; 2014
- Zhang H, Huo A, Li Z. Preparation of tetracyclic anthraquinone compounds with anticancer activity. WO059740A1; 2014
- Zhang H, Huo A, Li Z, et al. Preparation of tetracyclic anthraquinone compounds with anticancer activity. CN101225094A; 2008
- Wang X, Wang Y, Han S, et al. Bis[6-(nitrogen heterocycle substituted)-1,4-dihydroxyanthraquinone]platinum dichloride complex and its preparation method and application in cancer treatment. CN103554188A; 2014
- Chao H, Wang J, Kou J, et al. Preparation of anthraquinone polypyridyl ligand, its binuclear ruthenium complexes and their applications. CN103554140A; 2014
- Huang HS, Lee YR, Chen TC. Preparation of heterocyclic fused anthraquinone derivatives and pharmaceutical composition thereof useful in treatment of cancer. US0289028A1; 2013
- Huang HS, Chen TC, Cha TL. Methods for inhibiting cancer cell proliferation and inducing cancer cell apoptosis using anthraquinone derivative, anthra[2,1-c][1,2,5]thiadiazole-6,11-dione (NSC745885). US0122937A1; 2012
- Wang W, Zhang F, Bai Z. An emodin derivative with antitumor activity and its preparation method. CN102614158A; 2012
- Li Y, Zhang L. Emodin anthraquinone derivative in preparing anti-liver cancer medicine combination chemotherapeutic application. CN103356515A; 2013
- Shao J, Wang W, Du H. Monohydroxy di-n-decyl emodin quaternary ammonium salts with good antitumor activity and its preparation. CN102249941A; 2011
- Li Y, Zhang L, Wang Z. An application of amide anthraquinone derivatives in preparation of anticancer drug. CN104083362; 2014
- Mizushina Y, Takeuchi T, Kamisuki S, et al. Anthraquinone compounds and their use for pharmaceutical compositions, DNA polymerase inhibitors, and food compositions. JP194045A; 2013
- Zhang H. Preparation of tetracyclic anthraquinone compounds with anticancer activity. US0308646A1; 2012
- Kamal A, Ramu R, Khanna GBR. Preparation of anthraquinone derivatives as antitumor agents. IN254250A1; 2012
- Kamal A, Ramesh GBK, Rondla R. Pyrrolo[2,1-c][1,4]benzodiazepine- anthraquinone conjugates useful as antitumor agents. US0142272A1; 2006
- Zhang Z, Li X. Preparation of anthraquinone derivatives as Bcl-2 inhibitors. CN102731285A; 2012
- Wang C, Shao C, Zheng C. Anthraquinone dimer derivative alterporriol P with antitumor activity and its preparation and application. CN102633616A; 2012
- Shi L, Wang Z, Zhang G, et al. 1,4-Dihydroxy-2-formacyl-9,10-anthraquinone-like acylhydrazone compounds with good antitumor activity and the medical preparations for treating cancer. CN102617459A; 2012
- Schaffer M, Shaked Y, Ehrenberg B. Anthraquinones for use as radiosensitizers in cancer treatment. WO081022A1; 2012
- Hou H, Li D. 1,8-dihydroxy-3-acetyl-6-methyl-9,10-anthraquinone, 1,8-dihydroxy-3-methoxy-6-methyl-9,10-anthraquinone and 1,3,8-trimethoxy-6-methyl-9,10-anthraquinone as radiosensitizers targeting mitochondrias for treating nasopharyngeal carcinoma. CN102363044A; 2012
- Chang CWT. Preparation of anthraquinone analogs for inhibition of cell growth. WO021409A2; 2012
- Zhang G, Guo S, Zhang B, et al. Preparation of (S)-2-hydroxyalkyl-1,4-dihydroxy-9,10-anthraquinone and glycosyl conjugate for the treatment of cancer. CN102146107A; 2011
- Zhang G, Li L, Liu Q, et al. Analog containing anthraquinone ring-like antibiotic simple structure with good antitumor activity, its preparation process and application. CN102086219A; 2011
- Li Y, Zhang Y, Meng X, et al. Anthraquinone derivative and its lysine salt, their preparation method and antitumor application thereof. CN101786952A; 2010
- Yang Z, Sun H, Xiao H. The use of anthraquinone derivatives for preparation of medicaments against influenza and “bird flu” virus. WO071159A1; 2007
- Cleland JL, Wong A, Lalani AS. Treatment of hyperproliferative diseases with anthraquinones, and use with other agents or treatments. US0117784A1; 2007
- Nair MG, Cichewicz RH, Seeram NP, et al. Anticancer anthraquinones, isolation from Hemorocallis fulva, and methods of use. US6875746B1; 2005
- Cholody WM, Zang Y, Zuck K, et al. Anthraquinone dioximes as cell growth inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancers. WO059142A1; 2010
- Soriano S. Use of triterpenic and anthraquinone glycosides as substances exerting hydragogue activity on mucosa of the upper respiratory tract, for the treatment of upper respiratory tract diseases. WO035299A1; 2010
- Farjo R. STAT3-inhibiting compositions and methods using anthraquinone derivatives for the prevention of intraoccular neovascularization and inflammation. US0082470A1; 2009
- Lin CN, Won SJ, Teng CH. Synthesis of 1,3-dihydroxy-9,10-anthraquinone and 3-[(3-amino)propoxy]-9,10-anthraquinone derivatives as antitumor agents. US0027141A1; 2008
- Li B. Method for extracting anthraquinone glycosides from Lasianthus acuminatissimus with effect of inhibiting ovarian tumor. CN1884293A; 2006
- Li B. Application of anthraquinone glycoside compound 1-methoxy-2-methoxymethyl-3-hydroxy-9,10-anthraquinone-3-oxo-β-d-glucopyranoside. CN1721426A; 2006
- Shao C, Wang C, Yang K, et al. Anthraquinone derivative, and preparation method and application thereof as antibacterial agent. CN102603525A; 2012
- Igarashi M, Utsumi R, Watanabe T. Novel antibacterial anthraquinone compound, MK844-mF10, microbial manufacture thereof, Streptomyces producing it, and compositions containing it. JP201843A; 2011
- Yi Y, Huo J, Zhang W, et al. Reducing anthraquinone-like compounds with antimicrobial activity. CN101885676A; 2010
- Tian L, Lin W, Zheng L, et al. Novel anthraquinone compounds as fungicide. CN101274885A; 2008
- Yu D, Yang X, Ni H, et al. Use of anthraquinone derivatives as pesticides for controlling plant diseases. WO029958A1; 2005
- Bian Z, Tsang SW, Lu A, et al. Method of using rhein for treating pancreatic fibrotic conditions and tumors. US0323329A1; 2013
- Cheng Y, Liu K, Luo J et al. Anthraquinone derivative, drug composition of the same and application of the same in pharmacy. CN103288889A; 2013
- Wang C, Shao C, Zheng C. Two anthraquinone dimer derivatives, their preparation method and application in preparing antiviral drugs. CN102643186A; 2012
- Wang C, Shao C, Zheng C. Anthraquinones derivative from Alternaria sp., its preparation process and application in preparing the medical preparations as antiviral agent for inhibiting PRRSV. CN102531868A; 2012
- Ni Y, Zhang J, Sun Z, et al. Naphthodianthrone compound and salt for manufacturing imaging agent for biliary tract and gallstone laparoscopy. CN102526766A; 2012
- Walmsley A. Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use. WO056156A1; 2008
- Zhu S. Application of anthraquinone derivative (rheum emodin) to prepare antiviral medicine. CN1868465A; 2006
- Wang S, Zhong J, Kong D, et al. Use of 9,10-anthraquinone compounds in treating HCV infection. WO057443A1; 2010